A retrospective study of end-stage kidney disease patients on maintenance hemodialysis with renal osteodystrophy-associated fragility fractures

被引:16
作者
Xie, Lihua [1 ]
Hu, Xuantao [2 ]
Li, Wenzhao [2 ]
Ouyang, Zhengxiao [2 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Dept Nephrol, Changsha 410011, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp 2, Dept Orthoped, 139 Renmin Rd, Changsha 410011, Hunan, Peoples R China
关键词
ESRD; Fragility fracture; Risk factors; Prognosis; SERUM ALKALINE-PHOSPHATASE; HIP FRACTURE; ECONOMIC BURDEN; OSTEOPOROSIS; MORTALITY; RISK; CALCIFICATION; PREVALENCE;
D O I
10.1186/s12882-020-02224-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundNephropathy associated metabolic disorder induces high incidence of fragility fracture in end-stage renal disease (ESRD) patients. As the risk factors and prognosis of fragility fracture in ESRD patients are unclear, more research is needed. This study aimed to evaluate various risk factors for ESRD-related fragility fractures, explore factors affecting the prognosis of patients with such fractures, and provide information for prevention and treatment of renal osteopathy to improve the prognosis of patients.MethodsIn this retrospective case-control study, the case notes of 521 ESRD patients who received maintenance dialysis for at least 3months were examined. Finally, 44 patients diagnosed with fragility fractures were assigned to the fragility fracture (FF) group and 192 patients were included in the control group (CG). Demographic information, underlying diseases, nutritional, bone metabolism, and renal function parameters, along with the number and causes of any deaths, were recorded for multiple statistical analysis.ResultsThe FF group had increased incidences of essential hypertension and diabetes mellitus and higher serum calcium, corrected calcium, alkaline phosphatase, and hemoglobin levels. Immunoreactive parathyroid hormone (iPTH), total cholesterol (TC), and low density lipoprotein (LDL) levels were higher in the CG. Multivariate Cox regression analysis revealed that fragility fracture was an independent risk factor for all-cause mortality in ESRD patients (P < .001, RR: 4.877, 95% CI: 2.367-10.013).ConclusionsEssential hypertension and diabetes, high serum calcium and alkaline phosphatase levels, and reduced iPTH levels were risk factors for fragility fracture in ESRD patients. Maintaining iPTH and serum TC levels may protect against fragility fractures in them. Fragility fractures may yield poor prognosis and shorter lifespan. The presence of fragility fracture was an independent predictor of all-cause death in ESRD patients.
引用
收藏
页数:9
相关论文
共 50 条
[31]   Prevalence of Cardiovascular Disease in Patients with Chronic Kidney Disease and End-Stage Renal Disease in India: A Cross-Sectional Study [J].
Yellapantula, Balsubramaniam ;
Jhunjhunwala, Kush D. ;
Bhrushundi, Milind ;
Sharma, Ranjana .
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2025, 17 (SUPPL 1) :S630-S633
[32]   Experiences of Dietary Management and Social Adaptation in Young End-Stage Renal Disease Maintenance Hemodialysis Patients: A Qualitative Study [J].
Zhou, Linghan ;
Kang, Liping ;
Wang, Dongyang ;
Li, Qingmiao ;
Wei, Junfan ;
Li, Mengtian ;
Li, Meng ;
Li, Huawei .
PATIENT PREFERENCE AND ADHERENCE, 2025, 19 :1731-1745
[33]   Chronic obstructive pulmonary disease in patients with end-stage kidney disease on hemodialysis [J].
Plesner, Louis L. ;
Warming, Peder E. ;
Nielsen, Ture L. ;
Dalsgaard, Morten ;
Schou, Morten ;
Host, Ulla ;
Rydahl, Casper ;
Brandi, Lisbet ;
Kober, Lars ;
Vestbo, Jorgen ;
Iversen, Kasper .
HEMODIALYSIS INTERNATIONAL, 2016, 20 (01) :68-77
[34]   Determinant Effects of Average Fasting Plasma Glucose on Mortality in Diabetic End-Stage Renal Disease Patients on Maintenance Hemodialysis [J].
Lin, Yi-Chun ;
Lin, Yen-Chung ;
Chen, Hsi-Hsien ;
Chen, Tzen-Wen ;
Hsu, Chih-Cheng ;
Wu, Mai-Szu .
KIDNEY INTERNATIONAL REPORTS, 2017, 2 (01) :18-26
[35]   Treatment of psoriasis in end-stage renal disease patients is associated with decreased mortality: A retrospective cohort study [J].
Schwade, Mark J. ;
Tien, Lillie ;
Waller, Jennifer L. ;
Davis, Loretta S. ;
Baer, Stephanie L. ;
Mohammed, Azeem ;
Young, Lufei ;
Kheda, Mufaddal F. ;
Bollag, Wendy B. .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 362 (01) :24-33
[36]   Comparison of different assessments for evaluating malnutrition in Chinese patients with end-stage renal disease with maintenance hemodialysis [J].
Hou, Yue ;
Li, Xiujiang ;
Hong, Dongxu ;
Zou, Hongbin ;
Yang, Lizhi ;
Chen, Yan ;
Dou, Haichuan ;
Du, Yujun .
NUTRITION RESEARCH, 2012, 32 (04) :266-271
[37]   Causal factors of cardiovascular disease in end-stage renal disease with maintenance hemodialysis: a longitudinal and Mendelian randomization study [J].
Tian, Dandan ;
Xu, You ;
Wang, Ying ;
Zhu, Xirui ;
Huang, Chun ;
Liu, Min ;
Li, Panlong ;
Li, Xiangyong .
FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
[38]   Hyperuricemia is associated with decreased renal function and occurrence of end-stage renal disease in patients with microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective study [J].
Kwon, Hyeok Chan ;
Ahn, Sung Soo ;
Yoo, Byung-Woo ;
Yoo, Juyoung ;
Jung, Seung Min ;
Song, Jason Jungsik ;
Park, Yong-Beom ;
Lee, Sang-Won .
RHEUMATOLOGY INTERNATIONAL, 2020, 40 (07) :1089-1099
[39]   Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating Hemodialysis [J].
Hickson, LaTonya J. ;
Negrotto, Sara M. ;
Onuigbo, Macaulay ;
Scott, Christopher G. ;
Rule, Andrew D. ;
Norby, Suzanne M. ;
Albright, Robert C. ;
Casey, Edward T. ;
Dillon, John J. ;
Pellikka, Patricia A. ;
Pislaru, Sorin V. ;
Best, Patricia J. M. ;
Villarraga, Hector R. ;
Lin, Grace ;
Williams, Amy W. ;
Nkomo, Vuyisile T. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (10) :1173-1182
[40]   Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease [J].
Weir, Matthew R. ;
Fink, Jeffrey C. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2014, 23 (03) :306-313